Feds Want Input on Mental Health Clinic Quality Checks
Published Date: 6/26/2026
Notice
Summary
SAMHSA wants your thoughts on creating an independent accreditation system for clinics that get CCBHC-E grants, which help community mental health services grow. This new system will make sure clinics meet quality standards, cut down on paperwork, and offer consistent support nationwide. Comments are open until July 27, 2026, and funding will help clinics cover accreditation costs.
Analyzed Economic Effects
3 provisions identified: 3 benefits, 0 costs, 0 mixed.
Transition to Independent Accreditation
SAMHSA plans to move Certified Community Behavioral Health Clinic Expansion (CCBHC-E) grant recipients who are not certified by their state under a Medicaid CCBHC program from self-attestation to independent accreditation. The Joint Explanatory Statement allows program funds to be used by grantees to obtain required independent accreditation, and SAMHSA will consider accreditation costs when setting grant funding levels.
Approval and Oversight of Accrediting Bodies
SAMHSA will evaluate and approve independent accrediting bodies through a formal application and review process and establish a federal oversight framework to monitor approved accrediting bodies, handle disputes and appeals, and coordinate with states and providers. This framework is intended to ensure alignment with SAMHSA's CCBHC standards and consistent national determinations.
Technical Assistance and Reduced Burden
SAMHSA intends to provide targeted technical assistance and implementation support to states, CCBHCs, accrediting bodies, and other stakeholders to support the accreditation system and help reduce administrative burden. SAMHSA is seeking public input on what forms of technical assistance (for example, consultation, webinars, readiness tools, or checklists) would be most valuable.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-12975 — Agency Information Collection Activities: Submission for Office of Management and Budget Review (OMB); Comment Request
SAMHSA is restarting its check-up on the PATH program, which helps homeless people get support through local groups in all 50 states and U.S. territories. This evaluation happens every three years to make sure funds are used right and to find ways to improve the program. No big cost changes are expected, but the review includes surveys and interviews happening soon.
2026-12977 — Agency Information Collection Activities: Proposed Collection; Comment Request Proposed Project: Request To Publish the 30-Day Notices in the Federal Register To Solicit Public Comment on Information Collection for the Continued Approval and Updates for the Protection and Advocacy for Individuals With Mental Illness (PAIMI)-Revised Annual Program Performance Report (PPR)-OMB No. 0930-0169- DECISION
SAMHSA wants to update and keep collecting info from groups that help people with mental illness through the PAIMI program. They’re asking the public to comment on these changes before the current approval expires on July 31, 2026. This helps make sure the program runs smoothly without adding extra paperwork or costs.
2026-12646 — Fiscal Year (FY) 2026 Notice of Supplemental Funding Opportunity
SAMHSA is giving nearly $1.2 million extra funding to a 2024 grant winner to create a special fellowship program for substance use prevention. This program will train and support community and state workers, helping them get certified and ready for jobs by September 2029. It’s all about building a strong, skilled team to fight substance use in communities that need it most.
2026-10884 — Current List of HHS-Certified Laboratories and Instrumented Initial Testing Facilities Which Meet Minimum Standards To Engage in Urine and Oral Fluid Drug Testing for Federal Agencies
Hey federal agencies! This notice shares the up-to-date list of labs and testing sites approved to do urine and oral fluid drug tests that meet strict government rules. If a lab loses its certification, it’s dropped from the list until it’s fixed. Staying current helps keep drug testing fair and reliable, with no extra costs or delays for agencies.
2026-10723 — Agency Information Collection Activities: Proposed Collection; Comment Request
SAMHSA wants to keep collecting info from its grant recipients to check how well programs for substance abuse and mental health are doing. This helps them track progress and figure out what training or help grantees might need. If you’re involved with these grants, you might see no big changes, but your feedback on the process is welcome before the extension is approved.
2026-08506 — Current List of HHS-Certified Laboratories and Instrumented Initial Testing Facilities Which Meet Minimum Standards To Engage in Urine and Oral Fluid Drug Testing for Federal Agencies
HHS just dropped the latest list of labs and testing sites approved to do urine and oral fluid drug tests for federal workers. If a lab loses its certification, it’s taken off the list until it’s back in good standing. This update helps keep drug testing fair, reliable, and up-to-date for all federal agencies.
Previous / Next Documents
Previous: 2026-12882 — Agency Information Collection Activities; Submission for OMB Review; Comment Request; Benefit Appeals Report
The Department of Labor is asking for public feedback on a report that tracks how many benefit appeals happen and their outcomes. This info helps states manage appeals and plan budgets better. Comments are open until July 27, 2026, and the goal is to keep the process clear and easy for everyone involved.
Next: 2026-12884 — Agency Information Collection Activities; Proposed Collection; Comment Request; Time and Extent Applications for Nonprescription Drug Products
The FDA wants your thoughts on how they collect info about nonprescription drug applications, especially about timing and usage. This affects drug makers and anyone interested in over-the-counter meds. You’ve got until August 25, 2026, to share your comments—no fees, just your voice helping shape the process!